Delivery Order SPE2DB20D9331-SPE2DB23FL1K5
- Not listed
- This federal contract award is a delivery order issued to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,225.46, is a firm fixed-price delivery order placed under the Defense Logistics Agency's (DLA) SPE2DB program, a $499,999,999 indefinite delivery contract that runs through December 31, 2025. Under this award, DMS Pharmaceutical Group will supply the DLA with the medication Ketorolac 30 mg/ml...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,249.92, is for the supply of 30 mg/mL ketorolac injections. This award is part of a larger indefinite delivery contract (IDC) under the SPE2DB program, worth up to $499,999,999, which allows the DLA to issue delivery orders to DMS Pharmaceutical Group for a wide range of pharmaceutical...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $1,173.04 under an indefinite delivery contract with the Defense Logistics Agency to supply the pharmaceutical item ketorolac tromethamine. The delivery order was awarded on October 29, 2019 with a completion date of November 8, 2019. No set-aside designation was used for this award. DMS Pharmaceutical Group will fulfill the delivery order from its place of performance in Park Ridge, Illinois. As a woman-owned...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at fifteen thousand one hundred fifty dollars by the Defense Logistics Agency Troop Support Medical. This order is placed against an indefinite delivery contract held by DMS Pharmaceutical Group to supply various pharmaceutical items and medical supplies with a potential value of up to five million dollars through December 2025. Under this particular order, DMS Pharmaceutical Group will provide ketorolac...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,041.60 to DMS Pharmaceutical Group Inc. for the supply of Ketorolac Tromethamine, a nonsteroidal anti-inflammatory medication commonly used for pain management in military healthcare settings. This firm fixed-price delivery order, issued on June 27, 2025, with an ultimate completion date of July 7, 2025, represents a discrete purchase order under DMS Pharmaceutical Group's larger Indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,051.65 award is for the delivery of Ketorolac 30 mg/mL vials, a pain medication, to support the recurring medical supply needs of military health facilities. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
- This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The contract is for the supply of Ketorolac Trometham, a prescription medication, with a ceiling value of $3,749.76 and a period of performance through July 11, 2025. The contract is not designated as a set-aside. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC)...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $3,519.12 under an indefinite delivery contract with the Defense Logistics Agency to supply the pharmaceutical item ketorolac tromethamine. As a woman-owned small business, DMS Pharmaceutical Group will provide the requested product to Defense Logistics Agency Troop Support Medical facilities. DMS Pharmaceutical Group currently holds an indefinite delivery contract with the Defense Logistics Agency, valued at up...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $5,161.07 under an indefinite delivery contract with the Defense Logistics Agency to supply ketorolac tromethamine. The delivery order was issued on April 27, 2017 with a completion date of June 6, 2017. DMS Pharmaceutical Group will provide the pharmaceutical item to Defense Logistics Agency Troop Support Medical facilities located in Park Ridge, Illinois. As a woman-owned small business, DMS Pharmaceutical...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $26,253.57. The award is part of the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract, which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. Under this delivery order, DMS Pharmaceutical Group will provide a wide range of pharmaceutical products, including branded and generic...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB23FL1K5Delivery Order
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a $7,395.36 firm fixed-price delivery order placed under the Defense Logistics Agency's (DLA) SPE2DB program. The order is for the supply of 4561901111 - KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. The contract has an ultimate completion date of August 23, 2023 and does not utilize any set-aside designations. DMS Pharmaceutical Group is a key supplier of a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA), leveraging its status as a woman-owned small business to secure direct awards for the DLA's Medical Supply Chain programs. This delivery order is part of a larger $499,999,999 single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which runs through December 31, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 8/22/23 |